159 related articles for article (PubMed ID: 7802579)
1. Relation of epidermal growth factor receptor and estrogen receptor-independent pS2 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas.
Kirby RE; Lewandrowski KB; Southern JF; Compton CC; Warshaw AL
Arch Surg; 1995 Jan; 130(1):69-72. PubMed ID: 7802579
[TBL] [Abstract][Full Text] [Related]
2. Measurement of pS2 protein in pancreatic cyst fluids. Evidence for a potential role of pS2 protein in the pathogenesis of mucinous cystic tumors.
Yang JM; Lee J; Southern JF; Warshaw AL; Dhanak E; Lewandrowski KB
Int J Pancreatol; 1998 Dec; 24(3):181-6. PubMed ID: 9873952
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
Yeh TS; Jan YY; Chiu CT; Ho YB; Chen TC; Lee KF; Chan KM; Hsu JC; Hwang TL; Chen MF
Gut; 2002 Nov; 51(5):712-6. PubMed ID: 12377812
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.
Foekens JA; van Putten WL; Portengen H; Rodenburg CJ; Reubi JC; Berns PM; Henzen-Logmans SC; van der Burg ME; Alexieva-Figusch J; Klijn JG
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):815-21. PubMed ID: 2178364
[TBL] [Abstract][Full Text] [Related]
5. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
6. Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas.
Kuboki Y; Shiratori K; Hatori T; Fujita I; Kimijima A; Yamamoto M; Kobayashi M; Furukawa T
Mod Pathol; 2010 Aug; 23(8):1127-35. PubMed ID: 20495538
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
8. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
[TBL] [Abstract][Full Text] [Related]
9. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.
Thompson LD; Becker RC; Przygodzki RM; Adair CF; Heffess CS
Am J Surg Pathol; 1999 Jan; 23(1):1-16. PubMed ID: 9888699
[TBL] [Abstract][Full Text] [Related]
10. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic analysis of 92 cases of pancreatic cystic neoplasm].
Ji Y; Zhu XZ; Lou WH; Wang DQ; Jin DY; Zeng MS; Zeng HY
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):160-5. PubMed ID: 17535681
[TBL] [Abstract][Full Text] [Related]
12. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
[TBL] [Abstract][Full Text] [Related]
13. Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms.
Sano M; Driscoll DR; De Jesus-Monge WE; Klimstra DS; Lewis BC
Gastroenterology; 2014 Jan; 146(1):257-67. PubMed ID: 24067880
[TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary and pancreatic mucinous cystadenocarcinomas with mesenchymal stroma: analysis of estrogen receptors/progesterone receptors and expression of tumor-associated antigens.
Weihing RR; Shintaku IP; Geller SA; Petrovic LM
Mod Pathol; 1997 Apr; 10(4):372-9. PubMed ID: 9110301
[TBL] [Abstract][Full Text] [Related]
15. Mucinous cystic tumor of the pancreas: an analysis of FNA characteristics with an emphasis on the spectrum of malignancy associated features.
Dodd LG; Farrell TA; Layfield LJ
Diagn Cytopathol; 1995 Mar; 12(2):113-9. PubMed ID: 7774489
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic mucinous cystic neoplasm with sarcomatous stroma: a report of three cases.
Wenig BM; Albores-Saavedra J; Buetow PC; Heffess CS
Am J Surg Pathol; 1997 Jan; 21(1):70-80. PubMed ID: 8990143
[TBL] [Abstract][Full Text] [Related]
17. [The clinical and morphological characteristics of mucinous cystic tumors of the pancreas].
Dubova EA; Podgornova MN; Shchegolev AI
Arkh Patol; 2010; 72(5):30-2. PubMed ID: 21313764
[TBL] [Abstract][Full Text] [Related]
18. Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor, and progesterone receptors.
Hanby AM; McKee P; Jeffery M; Grayson W; Dublin E; Poulsom R; Maguire B
Am J Surg Pathol; 1998 Sep; 22(9):1125-31. PubMed ID: 9737246
[TBL] [Abstract][Full Text] [Related]
19. Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer.
Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Delivelioti K; Gogas J; Kyrkou K
Acta Cytol; 1997; 41(3):713-6. PubMed ID: 9167689
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
